510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1904-2021Class II

Philips Allura Xper System: Interventional Fluoroscopic X-Ray System Product No.: 722026, 722027, 722028...

Philips Medical Systems Nederland B.V. / initiated 2016-06-23 / Terminated / root cause: design

Philips Medical Systems Nederlands began a recall of Philips Allura Xper System: Interventional Fluoroscopic X-Ray System Product No.: 722026, 722027, 722028, 722029, 722035, 722038, and 722058 on . FDA classified it as Class II and gives the reason as "Certain low-voltage DC power supplies (DCPS) used in these products may be subject to an increased probability of failure. Failure of a DCPS may result in the sudden loss of imaging functionality or mechanical movement...". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-1904-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Philips Medical Systems Nederland B.V.
Product
Philips Allura Xper System: Interventional Fluoroscopic X-Ray System Product No.: 722026, 722027, 722028, 722029, 722035, 722038, and 722058.
Product code
OWB Interventional Fluoroscopic X-Ray System
Reason for recall
Certain low-voltage DC power supplies (DCPS) used in these products may be subject to an increased probability of failure. Failure of a DCPS may result in the sudden loss of imaging functionality or mechanical movement, depending on what subsystems the DCPS is powering.
Root cause tag
design
FDA root cause
Component design/selection
Action
On April 23, 2021, Philips Healthcare issued an Urgent Medical Device Correction notice to customers via letter notifying them that Philips Healthcare has discovered through trend analysis an increase in the failure rate of certain low-voltage DC power supplies (DCPS) used in these products. Each system contains multiple DCPS, some of which may be subject to an increased probability of failure. Failure of a DCPS may result in the sudden loss of imaging functionality or mechanical movement, depending on what subsystems the DCPS is powering. HOW TO IDENTIFY AFFECTED PRODUCTS: For systems mentioned above, If 'Rev 8.2.16 or Rev 8.2.17 appears in the lower (black) area of the start-up screen, the system is affected. Philips will be notifying customers with affected systems. ACTION TO BE TAKEN BY CUSTOMER / USER: The likelihood of a system failure occurring is remote, and the users are recommended to follow their pre-established procedures for managing potential patient safety in the event that the system shuts down. ACTIONS PLANNED BY PHILIPS: Philips will replace the affected DCPS. This service will be provided free of charge for all affected systems. A Philips Healthcare service representative will contact customers with affected devices to arrange for the service. .
Quantity in commerce
42 devices
Distribution
Worldwide distribution. US states of: AL, AZ, FL, GA, IL, MA, MO, NJ, OR, and VA; Netherlands, United Kingdom, Poland, Spain, France, Czech Republic, India, Brazil, Singapore, Japan, Colombia, United Arab Emirates, China, Russian Federation, Oman, and Mexico.
Product codes and lots
Product No.: 722026, 722027, 722028, 722029, 722035, 722038, and 722058. Date(s) of Distribution: 16-SEP-2014 - 04-MAY-2016.  System equipment numbers: 64937259 65862117 63304032 63151474 63250793 63303889 63304149 64140063 63855729 63516113 64077887 66407452 66350303 65342973 63210187 63511276;  66923399 66422060 64085323 61099178 64103799 67936786 66730784 66736708 66628236 63883590 64916638 64927462 65345691 66517161 66403768 63218881 67360962 69856976 65258983 66167983 64778594 61655917 65206981 67874859

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1904-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1904-2021Class IITerminatedVoluntary: Firm initiated